Abstracts deadline Friday 24 April 2026! Submit now
Abstracts deadline EXTENDED Friday 22 May 2026! Submit now
Samil Pharmaceutical has a long-standing presence in rheumatology in Korea through established medicines such as Zyloric, the original allopurinol, and Imuran, the original azathioprine. Building on this heritage, Samil continues to expand its rheumatology portfolio with new treatment options and strengthen its contribution to patient care.
Have you registered yet?
Don't miss your chance on being part of APLAR 2026 where live sessions feature the latest, best-in-class research and provide an opportunity to connect and stay apprised of the latest developments and innovations in the field.
Have you submitted your abstract yet?
Don't miss your chance on being part of APLAR 2026 where live sessions feature the latest, best-in-class research and provide an opportunity to connect and stay apprised of the latest developments and innovations in the field.
